There are now 18 disease-modifying therapies approved for MS in the U.S. and close to that number in many other countries. Some are proving to be more effective than others, but they also carry a risk of more serious side effects. What’s your preference greater benefits and higher risk or lower benefit but less risk?
One week of Gilenya down…so far, so good, though I can’t say that I notice much difference other than some stomach upset (that frankly might be a lingering side effect of Solumedrol a couple of weeks ago) one way or the other.
Hoping it will pump the brakes on new lesions and give my CNS some time without disease activity to recover. We’ll see.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.